FDA Cracks Down on Retailers Selling Unapproved Eye Drops with Silver
-
FDA warns CVS, Walgreens, and 6 other companies against selling unapproved eye drops that claim to treat conditions like pink eye, cataracts, and glaucoma.
-
The unapproved eye drops may contain silver, which can cause permanent skin and eye discoloration with long-term use.
-
CVS has stopped selling their "Pink Eye Relief" drops and is offering refunds to customers.
-
The FDA has given the companies 15 days to respond on how they will correct the violations before potential legal action.
-
The unapproved eye drops bypass defenses and pose an increased risk to users, according to the FDA.